Streamlined measurement of CAR T cell concentration, size, viability, and two-color phenotyping of CAR T cells during manufacturing.

Raymone Pajarillo,Luca Paruzzo, Alberto Caturan, Ositadimma Ugwuanyi, Griffin White,Puneeth Guruprasad,Hatcher J Ballard, Ruchi P Patel,Yunlin Zhang,Yong Gu Lee, SeokJae Albert Hong, Gregory M. Dittami,Marco Ruella

Cytotherapy(2024)

引用 0|浏览1
暂无评分
摘要
The success of CD19-targeted chimeric antigen receptor (CAR) T cell therapies has led to an exponential increase in the number of patients treated and new CAR T products being advanced. Therefore, there is a strong need to develop streamlined platforms that allow rapid, cost-effective, and accurate measurement of the key characteristics of CAR T cells during manufacturing, i.e., cell numbers, cell size (fL), viability, and basic phenotype. In this study, we compared the novel benchtop cell analyzer Moxi Go II (ORFLO Technologies), which enables simultaneous evaluation of all the above parameters, with the current standards, Multisizer Coulter Counter (cell counter) and BD LSR Fortessa (flow cytometer). Our results demonstrated that the Moxi GO II can accurately measure cell numbers and cell size (fL) while simultaneously assessing simple two-color flow cytometry parameters such as CAR T cell viability and CD4 or CAR expression. These measurements are comparable with the gold standard instruments, demonstrating that Moxi GO II is a promising platform for quickly monitoring CAR T cell growth and phenotype in research grade and clinical samples.
更多
查看译文
关键词
CAR T Cell Manufacturing,Flow cytometry,Cellular Immunotherapies
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要